Transition Therapeutics (TTHI) $75 Million Mixed Securities Shelf

September 29, 2009 3:22 PM EDT

Transition Therapeutics Inc. (Nasdaq: TTHI) filed a preliminary short form base shelf prospectus with securities regulatory authorities in Canada and a corresponding shelf registration statement with the United States Securities and Exchange Commission on Form F-10.

Once the shelf prospectus is cleared and the shelf registration statement becomes effective, these filings will, subject to securities regulatory requirements, provide for the potential offering in selected Canadian provinces and the United States of up to an aggregate amount of US$75 million of Transition's common shares, warrants, or a combination thereof, from time to time in one or more offerings over the next 25 months. This shelf prospectus is intended to give Transition the flexibility to support future opportunities when and if deemed appropriate by the Company. The terms of such future offerings, if any, will be established at the time of such offerings. At the time any of the securities covered by the shelf prospectus are offered for sale, a prospectus supplement containing specific information about the terms of any such offering will be provided. [SM]

Related Categories

Equity Offerings

Stocks Mentioned

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?